Seizure Success® and You!

Clinical trials and your role in developing new therapies for epilepsy...

How much do you know about clinical trials? How would I find one? Who participates?

If you currently take a medication prescribed by a doctor, it is available because patients like you participated in a clinical trial.

What is a clinical trial?
Clinical trials are a formal way to conduct human research focused on finding better ways to diagnose, prevent, treat and understand human disease.

Things to consider:

  • The treatments for seizures will not improve without patients participating in research.
  • Clinical trials help us understand if a promising new medication or device is safe.
  • Participating in a research study may give you access to a therapy not available to others with epilepsy.
  • Clinical trials not only research medication, they can also focus on disease prevention and quality of life.

For more information on clinical trials, please talk to your doctor or use the Trial Finder to identify a trial appropriate for you.

Featured Epilepsy Studies

The following are epilepsy studies that apply to particular groups within the Seizure Tracker™ population. Click a title to expand its details.

Description: Engage Therapeutics is recruiting adults living with epilepsy for StATES, a clinical trial of a novel seizure rescue treatment designed to stop or abort a seizure as it evolves. This trial will test the safety and efficacy of Staccato® Alprazolam in aborting partial (focal) or generalized seizures.

To participate you (or the person you care for) must have seizures that last at least three minutes or 2 seizures (any length) in 2 hours and these seizures must occur at least once per week.

The Staccato® system is a small, portable device that allows the individual to discreetly deliver an inhaled seizure rescue medication.
Description: Study design is a Phase IIb prospective multi-center, randomized, placebo-controlled, double-blind clinical trial. The goal will be to enroll 80 infants with Tuberous Sclerosis Complex who are less than 6 months of age prior to the onset of their first seizure.
Description: The purpose of the study is to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for necrotization or coagulation of epileptogenic foci in patients with intractable mesial temporal lobe epilepsy.
The study will include approximately 150 adult patients with drug-resistant MTLE treated at selected epilepsy centers across the United States. After the Visualase procedure, patients will be followed for 12 months and evaluated for freedom from seizures, quality of life, adverse events, and neuropsychological outcomes.
Some of the listings above may be sponsored content. All listings will pertain to some part of the Seizure Tracker™ population. Feel free to reach out to us if you think there is a research study that should be featured here.

Clinical Trial Finder
Age Group:  

Do I need to talk to my current doctor about a clinical trial for me?
You can. There are also people for every clinical trial that are available to answer any questions you may have. Their contact information can be found in the trial’s listing.